Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts

Author： Nukatsuka Mamoru   Saito Hitoshi   Nakagawa Fumio   Abe Masaaki   Uchida Junji   Shibata Jiro   Matsuo Ken-ichi   Noguchi Shinzaburo   Kiniwa Mamoru  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.128, Iss.2, 2011-07, pp. : 381-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

4.2. Aromatase Overexpression in Estrogen-Responsive Breast Cancer

By  

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 22-22

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Attenuation of Estrogen Receptor α (ERα) Signaling by Selenium in Breast Cancer Cells via Downregulation of ERα Gene Expression

By Shah Yatrik  

Breast Cancer Research and Treatment, Vol. 92, Iss. 3, 2005-08 ,pp. : 239-250

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen receptor and breast cancer

By Sommer S.   Fuqua S.A.W.  

Seminars in Cancer Biology, Vol. 11, Iss. 5, 2001-10 ,pp. : 339-352

Academic Press

Access to resources Recommend Favorite

RNA Sequencing of MCF-7 Breast Cancer Cells Identifies Novel Estrogen-Responsive Genes with Functional Estrogen Receptor-Binding Sites in the Vicinity of Their Transcription Start Sites

By Yamaga Ryonosuke  

Hormones and Cancer, Vol. 4, Iss. 4, 2013-08 ,pp. : 222-232

Springer Publishing Company

Access to resources Recommend Favorite

Hormone therapy and estrogen receptor expression in breast cancer

By Friman E. Isaksson   Mahlman M.   Nilsson B.   Skoog L.   Löfgren L.   Wilking N.   Von Schoultz E.  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 194-198

Informa Healthcare

Access to resources Recommend Favorite